Parkinson's Disease Trial, Recruiting NCT07434089 Sponsor: IRCCS Centro Neurolesi Bonino Pulejo Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT07434089
Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been diagnosed with Parkinson's disease according to the Movement Disorder Society's official diagnostic criteria
  • People aged between 40 and 70 years old
  • People with a moderate to advanced stage of Parkinson's disease (based on a standard medical rating scale called the Hoehn and Yahr scale, with a score between 2 and 4)
  • People who are able to walk on their own, even if some support is needed (confirm with trial site)

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People with Parkinson's disease who weigh more than 135 kg and are taller than 200 cm
  • People who have open wounds or bandages in areas that would be in contact with the equipment's harness
  • People with a long-term digestive or gut condition that affects how the body absorbs nutrients
  • People with a history of stomach ulcers or injuries, stomach removal surgery, or major bowel surgery
  • People with an ongoing infection, inflammatory condition, or autoimmune disease affecting the gut (such as Crohn's disease)
  • People who have had an active gut or digestive illness in the 4 weeks before joining the trial
  • People currently taking domperidone or any medication that may affect how the gut moves or functions
  • People who have used probiotics, steroids, anti-inflammatory drugs (such as ibuprofen), antibiotics, or antifungal medications in the 4 weeks before joining the trial and up to a certain follow-up point
  • People with a personal or family history that raises concern about bowel or gut cancer (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 30 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
IRCCS Centro Neurolesi Bonino Pulejo
Registry
ClinicalTrials.gov
Start date
20 October 2025
Est. completion
20 October 2027

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Relative abundance of bacterial and fungal taxa in fecal samples; Alpha Diversity of the Gut Microbiota; Beta Diversity of the Gut Microbiota; Distance Covered During the 6-Minute Walk Test; Time Required to Complete the 10-Meter Walk Test; Time Required to Complete the Timed Up and Go Test; Balance Performance Assessed by the Berg Balance Scale; Balance and Gait Performance Assessed by the Tinetti Scale; Fear of Falling Assessed by the Short Falls Efficacy Scale-International; Motor Symptom Severity Assessed by the MDS-UPDRS Part III (Motor Examination); Functional Independence Assessed by th...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov